Related Experiment Video
Updated: Jul 5, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Genetic and epigenetic changes in colon cancer
1Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA. wade.samowitz@aruplab.com
Experimental and Molecular Pathology
|May 17, 2008
Summary
Colon cancer is a complex disease with significant genetic heterogeneity, indicating multiple underlying conditions. Further genetic research promises new diagnostic and therapeutic strategies for personalized colon cancer treatment.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Colon cancer exhibits significant genetic heterogeneity, suggesting it comprises multiple distinct diseases.
- Understanding this heterogeneity is crucial for advancing diagnostic and therapeutic approaches.
Purpose of the Study:
- To explore the genetic heterogeneity of colon cancer.
- To highlight the association between genetic profiles, clinicopathologic features, and risk factors.
- To discuss the implications of emerging genetic data for diagnosis, therapy, and prevention.
Main Methods:
- Review of current genetic data and emerging technologies (e.g., expression microarrays, microRNAs).
- Analysis of associations between genetic subtypes, clinical features, and risk factors.
- Examination of recent findings on APC gene mutations in carcinogenesis.
Main Results:
- Genetic heterogeneity is a key characteristic of colon cancer.
- Refined genetic definitions reveal associations with clinical features and risk factors.
- New genetic insights, including APC mutations, challenge existing models of carcinogenesis.
Conclusions:
- Colon cancer's genetic diversity necessitates personalized diagnostic and therapeutic strategies.
- Emerging technologies will further elucidate this heterogeneity, guiding future clinical evaluations.
- Revisiting cancer prevention paradigms may be necessary based on new genetic findings.
Related Concept Videos
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...